(WAL) Western Alliance - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US9576381092
Stock: Deposits, Loans, Mortgages, Treasury Management
Total Rating 28
Risk 56
Buy Signal -0.91
| Risk 5d forecast | |
|---|---|
| Volatility | 59.0% |
| Relative Tail Risk | -14.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.06 |
| Alpha | -34.08 |
| Character TTM | |
|---|---|
| Beta | 1.606 |
| Beta Downside | 1.316 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.16% |
| CAGR/Max DD | 0.82 |
EPS (Earnings per Share)
Revenue
Description: WAL Western Alliance March 04, 2026
Western Alliance Bancorporation (WAL) is a bank holding company operating primarily in Arizona, California, and Nevada. It serves commercial and consumer clients.
The company offers a range of deposit products, including checking, savings, and money market accounts. It also provides treasury management services, a common offering in the regional banking sector.
WALs loan portfolio includes commercial and industrial loans, commercial real estate loans, and construction and land development loans. This diversified lending strategy is typical for regional banks aiming to serve various business needs.
Additional services include internet banking, wire transfers, and cash management solutions. The company also invests in securities, municipal and non-profit loans, and low-income housing tax credits, reflecting a broader financial services model beyond traditional lending.
For more detailed financial data and analysis on WAL, ValueRay provides comprehensive research tools.
Headlines to watch out for
- Net interest income growth hinges on interest rate environment
- Loan portfolio expansion drives revenue in key markets
- Deposit growth and cost of funds impact profitability
- Commercial real estate market health influences loan performance
- Regulatory scrutiny on regional banks could increase compliance costs
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 969.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.03 > 0.02 and ΔFCF/TA 0.48 > 1.0 |
| NWC/Revenue: -353.9% < 20% (prev -1216 %; Δ 862.1% < -1%) |
| CFO/TA -0.03 > 3% & CFO -2.68b > Net Income 969.0m |
| Net Debt (3.04b) to EBITDA (1.30b): 2.33 < 3 |
| Current Ratio: 0.56 > 1.5 & < 3 |
| Outstanding Shares: last quarter (109.3m) vs 12m ago -0.18% < -2% |
| Gross Margin: 61.24% > 18% (prev 0.59%; Δ 6065 % > 0.5%) |
| Asset Turnover: 6.10% > 50% (prev 6.19%; Δ -0.10% > 0%) |
| Interest Coverage Ratio: 0.47 > 6 (EBITDA TTM 1.30b / Interest Expense TTM 1.83b) |
Altman Z'' -0.97
| A: -0.20 (Total Current Assets 24.03b - Total Current Liabilities 42.77b) / Total Assets 92.77b |
| B: 0.06 (Retained Earnings 5.61b / Total Assets 92.77b) |
| C: 0.01 (EBIT TTM 851.5m / Avg Total Assets 86.85b) |
| D: 0.09 (Book Value of Equity 7.36b / Total Liabilities 84.83b) |
| Altman-Z'' Score: -0.97 = CCC |
Beneish M
| DSRI: none (Receivables none/none, Revenue 5.29b/5.01b) |
| GMI: 0.96 (GM 61.24% / 58.81%) |
| AQI: 0.83 (AQ_t 0.73 / AQ_t-1 0.89) |
| SGI: 1.06 (Revenue 5.29b / 5.01b) |
| TATA: 0.04 (NI 969.0m - CFO -2.68b) / TA 92.77b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of WAL shares?
As of March 11, 2026, the stock is trading at USD 73.39 with a total of 2,396,042 shares traded.
Over the past week, the price has changed by -9.88%, over one month by -23.26%, over three months by -11.02% and over the past year by +2.97%.
Over the past week, the price has changed by -9.88%, over one month by -23.26%, over three months by -11.02% and over the past year by +2.97%.
Is WAL a buy, sell or hold?
Western Alliance has received a consensus analysts rating of 4.53.
Therefore, it is recommended to buy WAL.
- StrongBuy: 9
- Buy: 5
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the WAL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 102.8 | 40.1% |
| Analysts Target Price | 102.8 | 40.1% |
WAL Fundamental Data Overview March 05, 2026
P/E Trailing = 9.1123
P/E Forward = 7.8864
P/S = 2.6379
P/B = 1.212
P/EG = 1.84
Revenue TTM = 5.29b USD
EBIT TTM = 851.5m USD
EBITDA TTM = 1.30b USD
Long Term Debt = 6.32b USD (from longTermDebt, last quarter)
Short Term Debt = 3.85b USD (from shortLongTermDebt, last quarter)
Debt = 6.64b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.04b USD (from netDebt column, last quarter)
Enterprise Value = -8.64b USD (8.75b + Debt 6.64b - CCE 24.03b)
Interest Coverage Ratio = 0.47 (Ebit TTM 851.5m / Interest Expense TTM 1.83b)
EV/FCF = 3.09x (Enterprise Value -8.64b / FCF TTM -2.79b)
FCF Yield = 32.32% (FCF TTM -2.79b / Enterprise Value -8.64b)
FCF Margin = -52.76% (FCF TTM -2.79b / Revenue TTM 5.29b)
Net Margin = 18.30% (Net Income TTM 969.0m / Revenue TTM 5.29b)
Gross Margin = 61.24% ((Revenue TTM 5.29b - Cost of Revenue TTM 2.05b) / Revenue TTM)
Gross Margin QoQ = 62.73% (prev 60.30%)
Tobins Q-Ratio = -0.09 (set to none) (Enterprise Value -8.64b / Total Assets 92.77b)
Interest Expense / Debt = 6.80% (Interest Expense 451.2m / Debt 6.64b)
Taxrate = 17.57% (62.5m / 355.7m)
NOPAT = 701.9m (EBIT 851.5m * (1 - 17.57%))
Current Ratio = 0.56 (Total Current Assets 24.03b / Total Current Liabilities 42.77b)
Debt / Equity = 0.87 (Debt 6.64b / totalStockholderEquity, last quarter 7.65b)
Debt / EBITDA = 2.33 (Net Debt 3.04b / EBITDA 1.30b)
Debt / FCF = -1.09 (negative FCF - burning cash) (Net Debt 3.04b / FCF TTM -2.79b)
Total Stockholder Equity = 7.27b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.12% (Net Income 969.0m / Total Assets 92.77b)
RoE = 13.33% (Net Income TTM 969.0m / Total Stockholder Equity 7.27b)
RoCE = 6.27% (EBIT 851.5m / Capital Employed (Equity 7.27b + L.T.Debt 6.32b))
RoIC = 5.56% (NOPAT 701.9m / Invested Capital 12.63b)
WACC = 9.15% (E(8.75b)/V(15.39b) * Re(11.83%) + D(6.64b)/V(15.39b) * Rd(6.80%) * (1-Tc(0.18)))
Discount Rate = 11.83% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.28%
[DCF] Fair Price = unknown (Cash Flow -2.79b)
EPS Correlation: -15.34 | EPS CAGR: 4.07% | SUE: 0.80 | # QB: 0
Revenue Correlation: 90.01 | Revenue CAGR: 26.78% | SUE: 2.65 | # QB: 1
EPS next Quarter (2026-06-30): EPS=2.45 | Chg7d=-0.008 | Chg30d=-0.012 | Revisions Net=-8 | Analysts=14
EPS current Year (2026-12-31): EPS=10.22 | Chg7d=-0.011 | Chg30d=-0.008 | Revisions Net=+1 | Growth EPS=+21.4% | Growth Revenue=+11.3%
EPS next Year (2027-12-31): EPS=11.90 | Chg7d=+0.002 | Chg30d=-0.010 | Revisions Net=+0 | Growth EPS=+16.4% | Growth Revenue=+8.2%
[Analyst] Revisions Ratio: -0.80 (1 Up / 9 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.9% (Discount Rate 11.8% - Earnings Yield 11.0%)
[Growth] Growth Spread = +14.3% (Analyst 15.1% - Implied 0.9%)
P/E Forward = 7.8864
P/S = 2.6379
P/B = 1.212
P/EG = 1.84
Revenue TTM = 5.29b USD
EBIT TTM = 851.5m USD
EBITDA TTM = 1.30b USD
Long Term Debt = 6.32b USD (from longTermDebt, last quarter)
Short Term Debt = 3.85b USD (from shortLongTermDebt, last quarter)
Debt = 6.64b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.04b USD (from netDebt column, last quarter)
Enterprise Value = -8.64b USD (8.75b + Debt 6.64b - CCE 24.03b)
Interest Coverage Ratio = 0.47 (Ebit TTM 851.5m / Interest Expense TTM 1.83b)
EV/FCF = 3.09x (Enterprise Value -8.64b / FCF TTM -2.79b)
FCF Yield = 32.32% (FCF TTM -2.79b / Enterprise Value -8.64b)
FCF Margin = -52.76% (FCF TTM -2.79b / Revenue TTM 5.29b)
Net Margin = 18.30% (Net Income TTM 969.0m / Revenue TTM 5.29b)
Gross Margin = 61.24% ((Revenue TTM 5.29b - Cost of Revenue TTM 2.05b) / Revenue TTM)
Gross Margin QoQ = 62.73% (prev 60.30%)
Tobins Q-Ratio = -0.09 (set to none) (Enterprise Value -8.64b / Total Assets 92.77b)
Interest Expense / Debt = 6.80% (Interest Expense 451.2m / Debt 6.64b)
Taxrate = 17.57% (62.5m / 355.7m)
NOPAT = 701.9m (EBIT 851.5m * (1 - 17.57%))
Current Ratio = 0.56 (Total Current Assets 24.03b / Total Current Liabilities 42.77b)
Debt / Equity = 0.87 (Debt 6.64b / totalStockholderEquity, last quarter 7.65b)
Debt / EBITDA = 2.33 (Net Debt 3.04b / EBITDA 1.30b)
Debt / FCF = -1.09 (negative FCF - burning cash) (Net Debt 3.04b / FCF TTM -2.79b)
Total Stockholder Equity = 7.27b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.12% (Net Income 969.0m / Total Assets 92.77b)
RoE = 13.33% (Net Income TTM 969.0m / Total Stockholder Equity 7.27b)
RoCE = 6.27% (EBIT 851.5m / Capital Employed (Equity 7.27b + L.T.Debt 6.32b))
RoIC = 5.56% (NOPAT 701.9m / Invested Capital 12.63b)
WACC = 9.15% (E(8.75b)/V(15.39b) * Re(11.83%) + D(6.64b)/V(15.39b) * Rd(6.80%) * (1-Tc(0.18)))
Discount Rate = 11.83% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.28%
[DCF] Fair Price = unknown (Cash Flow -2.79b)
EPS Correlation: -15.34 | EPS CAGR: 4.07% | SUE: 0.80 | # QB: 0
Revenue Correlation: 90.01 | Revenue CAGR: 26.78% | SUE: 2.65 | # QB: 1
EPS next Quarter (2026-06-30): EPS=2.45 | Chg7d=-0.008 | Chg30d=-0.012 | Revisions Net=-8 | Analysts=14
EPS current Year (2026-12-31): EPS=10.22 | Chg7d=-0.011 | Chg30d=-0.008 | Revisions Net=+1 | Growth EPS=+21.4% | Growth Revenue=+11.3%
EPS next Year (2027-12-31): EPS=11.90 | Chg7d=+0.002 | Chg30d=-0.010 | Revisions Net=+0 | Growth EPS=+16.4% | Growth Revenue=+8.2%
[Analyst] Revisions Ratio: -0.80 (1 Up / 9 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.9% (Discount Rate 11.8% - Earnings Yield 11.0%)
[Growth] Growth Spread = +14.3% (Analyst 15.1% - Implied 0.9%)